Literature DB >> 16030087

Interrogating DNA repair in cancer risk assessment.

Tamar Paz-Elizur, Dean E Brenner, Zvi Livneh.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16030087     DOI: 10.1158/1055-9965.EPI-14-7-ED

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  5 in total

Review 1.  Stable-isotope dilution LC–MS for quantitative biomarker analysis.

Authors:  Eugene Ciccimaro; Ian A Blair
Journal:  Bioanalysis       Date:  2010-02       Impact factor: 2.681

2.  Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR.

Authors:  Nicola Machella; Mary Beth Terry; Jennifer Zipprich; Irina Gurvich; Yuyan Liao; Ruby T Senie; David O Kennedy; Regina M Santella
Journal:  Carcinogenesis       Date:  2008-06-19       Impact factor: 4.944

Review 3.  DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention.

Authors:  Tamar Paz-Elizur; Ziv Sevilya; Yael Leitner-Dagan; Dalia Elinger; Laila C Roisman; Zvi Livneh
Journal:  Cancer Lett       Date:  2008-04-18       Impact factor: 8.679

4.  Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk.

Authors:  Ziv Sevilya; Yael Leitner-Dagan; Mila Pinchev; Ran Kremer; Dalia Elinger; Flavio Lejbkowicz; Hedy S Rennert; Laurence S Freedman; Gad Rennert; Tamar Paz-Elizur; Zvi Livneh
Journal:  Carcinogenesis       Date:  2015-06-04       Impact factor: 4.944

5.  N-methylpurine DNA glycosylase and OGG1 DNA repair activities: opposite associations with lung cancer risk.

Authors:  Yael Leitner-Dagan; Ziv Sevilya; Mila Pinchev; Ran Kramer; Dalia Elinger; Laila C Roisman; Hedy S Rennert; Edna Schechtman; Laurence Freedman; Gad Rennert; Zvi Livneh; Tamar Paz-Elizur
Journal:  J Natl Cancer Inst       Date:  2012-10-27       Impact factor: 13.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.